Cheap, yes. Without significant side-effects, no. The nucleoside analogues currently used to treat HSV aren't super effective, and do sometimes carry harmful s

Cheap, yes. Without significant side-effects, no. The nucleoside analogues currently used to treat HSV aren't super effective, and do sometimes carry harmful side-effects. We may have a more effective treatment in Pritelivir, if this ever gets through clinical trials. It has a different mechanism than acyclovir et al — it is a helicase primase inhibitor. It may even be true that HSV is more effectively treated when helicase primase inhibitors and nucleoside analogues work in conjunction.